https://www.caddra.ca/medication-updates/2017-03-22T18:17:28-04:00https://www.caddra.ca/cardiac-updates/2017-03-22T18:17:28-04:00https://www.caddra.ca/cardiac-risk-assessment-before-stimulant-medication-use/2017-03-22T18:17:28-04:00https://www.caddra.ca/new-long-acting-psychostimulants-for-adhd-treatment-launched-in-canada/2017-03-22T18:17:28-04:00https://www.caddra.ca/caddra-response-to-new-adhd-generic-medication-novo-methylphenidate-er-c/2017-04-26T13:55:21-04:00https://www.caddra.ca/vyvanse-now-approved-for-all-ages-by-health-canada/2017-03-22T18:17:28-04:00https://www.caddra.ca/vyvanse-approved-on-ontario-formulary/2017-03-22T18:17:28-04:00https://www.caddra.ca/caddra-guide-to-provincial-formularies-long-acting-medications/2025-11-08T07:27:10-05:00https://www.caddra.ca/caddra-support-for-cpa-position-paper-on-newer-medications/2017-04-26T13:53:34-04:00https://www.caddra.ca/new-health-canada-information-on-strattera/2017-03-22T18:17:27-04:00https://www.caddra.ca/new-prescribing-regulations-for-adhd-medication-in-ontario/2017-03-22T18:17:59-04:00https://www.caddra.ca/new-aap-guidelines-on-adhd/2017-03-22T17:01:34-04:00https://www.caddra.ca/caddra-rebuttal-in-national-post/2017-04-26T13:43:14-04:00https://www.caddra.ca/caddra-response-to-toronto-star/2017-04-26T13:45:37-04:00https://www.caddra.ca/caddra-response-to-health-canada-alert/2025-06-10T11:31:48-04:00https://www.caddra.ca/bc-adhd-advocacy-meeting-friday-16-october/2017-03-22T17:03:54-04:00https://www.caddra.ca/dispelling-the-myths-misinformation-about-adhd/2017-03-22T17:03:54-04:00https://www.caddra.ca/request-for-intuniv-addition-to-ontario-forumulary/2025-06-10T11:31:05-04:00https://www.caddra.ca/new-caddra-transition-form/2017-03-22T17:03:54-04:00https://www.caddra.ca/call-to-bc-government-extend-coverage-to-all-long-acting-meds/2025-06-10T11:30:01-04:00https://www.caddra.ca/odprn-report-released-in-ontario/2025-06-10T11:26:32-04:00https://www.caddra.ca/public-funding-disparity-across-provinces-for-adhd-medication/2025-06-10T11:23:00-04:00https://www.caddra.ca/bc-physicians-campaign-to-add-physician-voice-to-pharmacare-adhd-review/2025-06-10T11:22:02-04:00https://www.caddra.ca/health-canada-product-monograph-update-intuniv-guanfacine/2018-02-28T20:57:54-05:00https://www.caddra.ca/invitation-to-2017-pas-spring-conference-and-caddra-adhd-institute-workshops/2025-11-25T13:40:17-05:00https://www.caddra.ca/new-medication-option-for-adults-with-adhd-in-canada/2018-02-28T20:25:19-05:00https://www.caddra.ca/bc-patients-urged-to-support-caddac-campaign/2018-02-28T20:49:05-05:00https://www.caddra.ca/update-on-bc-colleges-stimulant-prescribing-standards/2018-04-26T11:25:23-04:00https://www.caddra.ca/healthcare-professionals-please-complete-our-disability-tax-credit-survey/2019-01-18T10:01:51-05:00https://www.caddra.ca/cannabis-use-and-driving-related-performance-in-young-recreational-users-a-within-subject-randomized-clinical-trial/2019-02-27T09:55:28-05:00https://www.caddra.ca/treatment-patterns-and-costs-among-children-with-adhd/2019-02-27T10:04:08-05:00https://www.caddra.ca/dimensions-of-impulsivity/2019-02-28T09:44:07-05:00https://www.caddra.ca/disability-tax-credit-survey-an-update/2019-03-04T12:53:10-05:00https://www.caddra.ca/predictors-and-trajectories-of-response-to-the-homework-organization-and-planning-skills-hops-intervention-for-adolescents-with-adhd/2019-03-06T09:47:43-05:00https://www.caddra.ca/sustained-impact-of-a-sleep-intervention-and-moderators-of-treatment-outcome-for-children-with-adhd-2/2019-03-13T09:27:59-04:00https://www.caddra.ca/foquest-receives-approval-for-expanded-indication-for-children-and-adolescents-with-adhd/2019-03-14T11:58:52-04:00https://www.caddra.ca/prescribing-for-young-people-with-attention-deficit-hyperactivity-disorder-in-uk-primary-care/2019-03-20T09:32:38-04:00https://www.caddra.ca/attention-deficit-hyperactivity-disorder-school-performance-and-effect-of-medication-2/2019-03-27T09:37:28-04:00https://www.caddra.ca/shortened-sleep-duration-causes-sleepiness-inattention-and-oppositionality-in-adolescents-with-adhd/2019-04-03T09:25:16-04:00https://www.caddra.ca/new-england-journal-of-medicine-nejm-adhd-medication-and-psychosis-study/2019-04-12T12:59:18-04:00https://www.caddra.ca/evidence-of-concurrent-and-prospective-associations-between-early-maltreatment-and-adhd-through-childhood-and-adolescence/2019-04-10T10:25:08-04:00https://www.caddra.ca/attention-deficit-hyperactivity-disorder-symptoms-are-associated-with-lower-adaptive-behavior-skills-in-children-with-autism/2019-05-15T10:19:45-04:00https://www.caddra.ca/piloting-a-sequential-multiple-assignment-randomized-trial-for-mothers-with-attention-deficit-hyperactivity-disorder-and-their-at-risk-young-children/2019-05-22T10:11:28-04:00https://www.caddra.ca/sleep-and-daytime-sleepiness-in-adolescents-with-and-without-adhd-differences-across-ratings-daily-diary-and-actigraphy/2019-05-29T09:07:14-04:00https://www.caddra.ca/caddra-and-caddac-respond-to-the-toronto-district-school-boards-finance-budget-and-enrollment-committee-regarding-funding-cuts-to-support-services-psychology-staff/2019-06-04T12:55:21-04:00https://www.caddra.ca/new-formulations-of-stimulants-an-update-for-clinicians/2019-06-05T11:06:19-04:00https://www.caddra.ca/a-9-year-follow-up-of-attention-deficit-hyperactivity-disorder-in-a-population/2019-06-11T11:20:50-04:00https://www.caddra.ca/clinical-implications-of-the-perception-of-time-in-attention-deficit-hyperactivity-disorder-adhd-a-review/2019-09-18T10:07:54-04:00https://www.caddra.ca/long-term-effects-of-multimodal-treatment-on-adult-adhd-symptoms-follow-up-analysis-of-the-compas-trial/2019-06-26T09:02:54-04:00https://www.caddra.ca/a-novel-text-message-intervention-to-improve-adherence-to-stimulants-in-adults-with-adhd/2019-07-02T12:20:03-04:00https://www.caddra.ca/association-between-sleep-duration-and-attention-deficit-hyperactivity-disorder-a-systematic-review-and-meta-analysis-of-observational-studies/2019-07-09T08:52:18-04:00https://www.caddra.ca/expectancy-effects-on-self-reported-attention-deficit-hyperactivity-disorder-symptoms-in-simulated-neurofeedback-a-pilot-study/2019-07-09T09:02:54-04:00https://www.caddra.ca/new-indication-and-new-reimbursement-codes-in-quebec/2019-07-10T15:09:59-04:00https://www.caddra.ca/first-chewable-adhd-treatment-authorized-by-health-canada/2019-07-11T09:35:20-04:00https://www.caddra.ca/bending-the-curve-a-community-based-behavioral-parent-training-model-to-address-adhd-related-concerns-in-the-voluntary-sector-in-denmark/2019-07-15T10:11:04-04:00https://www.caddra.ca/beyond-stimulants-a-systematic-review-of-randomized-controlled-trials-assessing-novel-compounds-for-adhd/2019-07-15T10:20:50-04:00https://www.caddra.ca/evaluation-of-a-structured-skills-training-group-for-adolescents-with-adhd-study-protocol-of-a-randomized-controlled-trial/2019-07-15T10:32:10-04:00https://www.caddra.ca/methylphenidate-and-the-risk-of-psychosis-in-adolescents-and-young-adults-a-population-based-cohort-study/2019-07-15T10:41:19-04:00https://www.caddra.ca/caddra-summary-advisory-council-on-the-implementation-of-national-pharmacare-report/2019-07-25T10:21:39-04:00https://www.caddra.ca/slow-processing-speed-and-sluggish-cognitive-tempo-in-pediatric-adhd-evidence-for-differentiation-of-functional-correlates/2019-08-08T09:34:46-04:00https://www.caddra.ca/subclinical-scores-in-self-report-based-screening-tools-for-attention-deficits-correlate-with-cognitive-traits-in-typical-evening-type-adults-tested-in-the-morning/2019-08-08T09:44:58-04:00https://www.caddra.ca/a-multi-factorial-perspective-on-adhd-and-odd-in-school-aged-children-what-is-the-role-of-cognitive-regulation-temperament-and-parental-support/2019-08-08T10:11:44-04:00https://www.caddra.ca/clinical-correlates-of-mind-wandering-in-adults-with-adhd/2019-08-08T10:28:25-04:00https://www.caddra.ca/adverse-drug-reactions-related-to-mood-and-emotion-in-pediatric-patients-treated-for-adhd/2019-09-23T10:15:02-04:00https://www.caddra.ca/cohort-change-in-the-prevalence-of-adhd-among-u-s-adults-evidence-of-a-gender-specific-historical-period-effect/2019-10-01T13:23:14-04:00https://www.caddra.ca/emotion-regulation-in-participants-diagnosed-with-attention-deficit-hyperactivity-disorder-before-and-after-an-emotion-regulation-intervention/2019-10-09T10:59:45-04:00https://www.caddra.ca/impact-of-a-behavioral-intervention-delivered-by-pediatricians-or-psychologists-on-sleep-problems-in-children-with-adhd-a-cluster-randomized-translational-trial/2019-10-16T09:24:00-04:00https://www.caddra.ca/the-relationship-between-chronotype-and-obesity-in-children-and-adolescent-with-attention-deficit-hyperactivity-disorder/2019-10-22T11:48:18-04:00https://www.caddra.ca/intraindividual-variability-of-sleep-wake-patterns-in-adolescents-with-and-without-attention-deficit-hyperactivity-disorder/2019-10-30T10:25:18-04:00https://www.caddra.ca/a-comparison-of-efficacy-between-cognitive-behavioral-therapy-cbt-and-cbt-combined-with-medication-in-adults-with-adhd/2019-11-06T10:25:44-05:00https://www.caddra.ca/the-association-between-child-abuse-and-emotional-and-behavioral-problems-in-chinese-school-aged-boys-with-attention-deficit-hyperactivity-disorder/2019-11-13T10:27:03-05:00https://www.caddra.ca/effects-and-clinical-feasibility-of-a-behavioral-treatment-for-sleep-problems-in-adult-attention-deficit-hyperactivity-disorder-adhd-a-pragmatic-within-group-pilot-evaluation/2019-11-20T10:10:52-05:00https://www.caddra.ca/antipsychotic-treatment-among-youths-with-attention-deficit-hyperactivity-disorder/2019-11-27T10:27:00-05:00https://www.caddra.ca/suicidal-behaviour-among-persons-with-attention-deficit-hyperactivity-disorder/2019-12-04T10:16:37-05:00https://www.caddra.ca/trajectories-of-depressive-symptoms-in-adolescence-the-interplay-of-maternal-emotion-regulation-difficulties-and-youth-adhd-symptomatology/2019-12-11T10:23:55-05:00https://www.caddra.ca/associations-between-family-and-community-protective-factors-and-attention-deficit-hyperactivity-disorder-outcomes-among-us-children/2019-12-18T11:51:07-05:00https://www.caddra.ca/autistic-spectrum-disorder-symptoms-in-children-and-adolescents-with-adhd-a-meta-analytical-review/2020-01-02T10:16:30-05:00https://www.caddra.ca/neurological-and-psychiatric-adverse-effects-of-long-term-methylphenidate-treatment-in-adhd-a-map-of-the-current-evidence/2020-01-08T10:12:50-05:00https://www.caddra.ca/the-association-between-autism-symptoms-and-child-functioning-in-a-sample-with-adhd-recruited-from-the-community/2020-01-15T10:12:50-05:00https://www.caddra.ca/academic-motivation-deficits-in-adolescents-with-adhd-and-associations-with-academic-functioning/2020-01-22T10:08:55-05:00https://www.caddra.ca/intuniv-added-to-ontario-formulary/2020-01-28T08:14:54-05:00https://www.caddra.ca/recent-trends-in-the-prescribing-of-adhd-medications-in-canadian-primary-care/2020-01-29T10:08:18-05:00https://www.caddra.ca/telemedicine-in-the-management-of-adhd-literature-review-of-telemedicine-in-adhd/2020-02-05T10:26:28-05:00https://www.caddra.ca/academic-impairment-among-high-school-students-with-adhd-the-role-of-motivation-and-goal-directed-executive-functions/2020-02-12T10:10:15-05:00https://www.caddra.ca/the-role-of-sleep-duration-and-sleep-problems-during-childhood-in-the-development-of-adhd-in-adolescence-findings-from-a-population-based-birth-cohort/2020-02-20T12:39:17-05:00https://www.caddra.ca/executive-functioning-outcomes-over-6-months-of-atomoxetine-for-adults/2020-02-26T10:22:21-05:00https://www.caddra.ca/executive-and-daily-life-functioning-influence-the-relationship-between-adhd-and-mood-symptoms-in-university-students/2020-03-04T10:21:43-05:00https://www.caddra.ca/impact-of-adhd-on-household-chores/2020-03-11T10:21:27-04:00https://www.caddra.ca/attention-deficit-hyperactivity-disorder-adhd/2020-03-18T11:00:14-04:00https://www.caddra.ca/new-health-canada-temporary-exemptions-for-prescriptions-of-controlled-substances-including-psychostimulants/2020-03-25T10:06:35-04:00https://www.caddra.ca/interventions-for-adolescents-with-adhd-to-improve-peer-social-functioning/2020-03-25T10:35:33-04:00https://www.caddra.ca/vyvanse-chewable-tablet-added-to-ontario-formulary/2020-04-02T12:06:53-04:00https://www.caddra.ca/an-innovative-sms-intervention-to-improve-adherence-to-stimulants-in-children-with-adhd-preliminary-findings/2020-04-01T10:20:02-04:00https://www.caddra.ca/cumulative-social-disadvantage-and-risk-of-attention-deficit-hyperactivity-disorder-results-from-a-nationwide-cohort-study/2020-04-08T10:41:39-04:00https://www.caddra.ca/observation-and-comparison-of-social-abilities-in-attention-deficit-hyperactivity-disorder-and-autism-spectrum-disorder-children/2020-04-22T10:31:03-04:00https://www.caddra.ca/emotion-dysregulation-in-adults-with-attention-deficit-hyperactivity-disorder-a-meta-analysis/2020-04-29T10:30:20-04:00https://www.caddra.ca/interventions-for-adolescents-with-adhd-to-improve-peer-social-functioning-a-systematic-review-and-meta-analysis/2020-05-06T10:09:06-04:00https://www.caddra.ca/impact-of-sleep-restriction-on-affective-functioning-in-adolescents-with-attention-deficit-hyperactivity-disorder/2020-05-13T10:53:51-04:00https://www.caddra.ca/research-review-the-strength-of-the-genetic-overlap-between-adhd-and-other-psychiatric-symptoms-a-systematic-review-and-meta-analysis/2020-05-20T10:18:12-04:00https://www.caddra.ca/adherence-to-lifestyle-recommendations-and-adhd-a-population-based-study-of-children-aged-10-11-years/2020-05-27T12:07:13-04:00https://www.caddra.ca/caffeine-use-and-associations-with-sleep-in-adolescents-with-and-without-adhd/2020-06-03T10:28:05-04:00https://www.caddra.ca/consortium-neuroscience-of-attention-deficit-hyperactivity-disorder-and-autism-spectrum-disorder-the-enigma-adventure/2020-06-10T15:43:03-04:00https://www.caddra.ca/british-columbia-pharmacare-update/2020-06-15T14:12:45-04:00https://www.caddra.ca/parenting-stress-and-family-resilience-affect-the-association-of-adverse-childhood-experiences-with-childrens-mental-health/2020-06-17T10:45:53-04:00https://www.caddra.ca/frequency-and-individual-severity-of-arterial-blood-pressure-changes-in-children-and-adolescents-with-attention-deficit-hyperactivity-disorder-treated-with-methylphenidate-hydrochloride-a-prospecti/2020-06-24T13:29:03-04:00https://www.caddra.ca/endeavorrx-adhd-video-game-a-caddra-information-sheet/2020-06-26T10:48:35-04:00https://www.caddra.ca/what-is-the-link-between-attention-deficit-hyperactivity-disorder-and-sleep-disturbance-a-multimodal-examination-of-longitudinal-relationships-and-brain-structure-using-large-scale-population-based-c/2020-07-03T11:39:48-04:00https://www.caddra.ca/primary-care-management-of-children-with-attention-deficit-hyperactivity-disorder-appears-more-assertive-following-brief-psychiatric-intervention-compared-with-single-session-consultation/2020-07-08T10:37:43-04:00https://www.caddra.ca/safety-of-80-antidepressants-antipsychotics-anti-attention-deficit-hyperactivity-medications-and-mood-stabilizers-in-children-and-adolescents-with-psychiatric-disorders-a-large-scale-systematic-met/2020-07-15T10:28:32-04:00https://www.caddra.ca/association-between-methylphenidate-treatment-and-risk-of-seizure-a-population-based-self-controlled-case-series-study/2020-07-22T10:15:44-04:00https://www.caddra.ca/effect-of-parent-training-on-health-related-quality-of-life-in-preschool-children-with-attention-deficit-hyperactivity-disorder-a-secondary-analysis-of-data-from-a-randomized-controlled-trial/2020-07-29T10:39:56-04:00https://www.caddra.ca/adult-attention-deficit-hyperactivity-disorder-clinic-an-inter-professional-collaboration/2020-08-05T10:24:28-04:00https://www.caddra.ca/perspective-on-melatonin-use-for-sleep-problems-in-autism-and-attention-deficit-hyperactivity-disorder-a-systematic-review-of-randomized-clinical-trials/2020-08-12T10:26:46-04:00https://www.caddra.ca/adhd-as-a-risk-factor-for-infection-with-covid-19/2020-08-19T10:11:39-04:00https://www.caddra.ca/lisdexamfetamine-dimesylate-for-preschool-children-with-attention-deficit-hyperactivity-disorder/2020-08-26T10:22:47-04:00https://www.caddra.ca/comparison-of-accommodations-and-interventions-for-youth-with-adhd-a-randomized-controlled-trial/2020-09-02T10:16:14-04:00https://www.caddra.ca/review-of-clinical-outcome-assessments-in-pediatric-attention-deficit-hyperactivity-disorder/2020-09-09T10:20:58-04:00https://www.caddra.ca/efficacy-and-safety-of-guanfacine-extended-release-in-the-treatment-of-attention-deficit-hyperactivity-disorder-in-adults-results-of-a-randomized-double-blind-placebo-controlled-study/2020-09-16T10:26:06-04:00https://www.caddra.ca/practitioner-review-pharmacological-treatment-of-attention-deficit-hyperactivity-disorder-symptoms-in-children-and-youth-with-autism-spectrum-disorder-a-systematic-review-and-meta-analysis/2020-09-23T10:15:57-04:00https://www.caddra.ca/do-parents-adhd-symptoms-affect-treatment-for-their-children/2020-09-30T10:25:30-04:00https://www.caddra.ca/feasibility-acceptability-and-effectiveness-of-a-new-cognitive-behavioral-intervention-for-college-students-with-adhd/2020-10-07T10:20:30-04:00https://www.caddra.ca/cannabis-and-adhd-a-caddra-policy-statement/2026-05-22T09:19:33-04:00https://www.caddra.ca/an-rct-of-an-online-parenting-program-for-parents-of-preschool-aged-children-with-adhd-symptoms/2020-10-14T10:10:59-04:00https://www.caddra.ca/acute-effects-of-parent-stimulant-medication-versus-behavioral-parent-training-on-mothers-adhd-parenting-behavior-and-at-risk-children/2020-10-21T10:07:19-04:00https://www.caddra.ca/revisiting-the-effect-of-varying-the-number-of-response-alternatives-in-clinical-assessment-evidence-from-measuring-adhd-symptoms/2020-10-28T10:12:52-04:00https://www.caddra.ca/social-and-economic-costs-of-attention-deficit-hyperactivity-disorder-across-the-lifespan/2020-11-04T10:19:26-05:00https://www.caddra.ca/lifetime-co-occurring-psychiatric-disorders-in-newly-diagnosed-adults-with-attention-deficit-hyperactivity-disorder-adhdor-and-autism-spectrum-disorder-asd/2020-11-11T10:17:24-05:00https://www.caddra.ca/feasibility-trial-of-the-dialectical-behavior-therapy-skills-training-group-as-add-on-treatment-for-adults-with-attention-deficit-hyperactivity-disorder/2020-11-18T10:16:12-05:00https://www.caddra.ca/attention-deficit-hyperactivity-disorder-medication-and-risk-of-suicide-attempt-a-meta-analysis-of-observational-studies/2020-11-25T10:11:44-05:00https://www.caddra.ca/mindful-parenting-behaviors-and-emotional-self-regulation-in-children-with-adhd-and-controls/2020-12-02T10:18:08-05:00https://www.caddra.ca/relative-frequency-of-psychiatric-neurodevelopmental-and-somatic-symptoms-as-reported-by-mothers-of-children-with-autism-compared-with-adhd-and-typical-samples/2020-12-09T10:14:05-05:00https://www.caddra.ca/remote-learning-during-covid-19/2020-12-16T10:15:53-05:00https://www.caddra.ca/attention-deficit-hyperactivity-disorder-symptoms-in-young-children-with-autism-spectrum-disorder/2020-12-23T10:10:38-05:00https://www.caddra.ca/helping-clinicians-to-detect-odd-in-children-with-adhd-in-clinical-settings/2021-01-04T09:29:33-05:00https://www.caddra.ca/effects-of-chronotherapy-on-circadian-rhythm-and-adhd-symptoms-in-adults/2021-01-06T10:14:05-05:00https://www.caddra.ca/chronic-physical-activity-for-adhd-and-or-autism-spectrum-disorder-in-children-a-meta-analysis-of-randomized-controlled-trials/2021-01-13T10:20:07-05:00https://www.caddra.ca/college-readiness-differences-between-first-year-undergraduates-with-and-without-adhd/2021-01-20T10:06:55-05:00https://www.caddra.ca/chronotypes-and-trauma-reactions-in-children-with-adhd-in-home-confinement-of-covid-19-full-mediation-effect-of-sleep-problems/2021-01-27T10:34:39-05:00https://www.caddra.ca/theory-of-mind-in-adhd-a-proposal-to-improve-working-memory-through-the-stimulation-of-the-theory-of-mind/2021-02-03T10:10:05-05:00https://www.caddra.ca/the-effects-of-adhd-teacher-training-programs-on-teachers-and-pupils-a-systematic-review-and-meta-analysis/2021-02-10T10:20:19-05:00https://www.caddra.ca/the-course-of-adhd-during-pregnancy/2021-02-17T10:14:45-05:00https://www.caddra.ca/physical-health-media-use-and-mental-health-in-children-and-adolescents-with-adhd-during-the-covid-19-pandemic-in-australia/2021-02-24T10:16:22-05:00https://www.caddra.ca/the-unique-effects-of-maternal-adhd-symptoms-and-emotion-dysregulation-on-parenting-behavior/2021-03-03T10:15:19-05:00https://www.caddra.ca/unique-associations-between-specific-attention-deficit-hyperactivity-disorder-symptoms-and-related-functional-impairments/2021-03-10T10:21:23-05:00https://www.caddra.ca/medications-for-adhd-in-individuals-with-or-without-coexisting-autism-spectrum-disorder-analysis-of-data-from-the-swedish-prescribed-drug-register/2021-03-17T10:12:01-04:00https://www.caddra.ca/defining-the-role-of-exposure-to-aces-in-adhd-examination-in-a-national-sample-of-us-children/2021-03-24T10:16:36-04:00https://www.caddra.ca/time-perception-deficits-in-children-and-adolescents-with-adhd-a-meta-analysis/2021-03-31T10:13:39-04:00https://www.caddra.ca/time-knowledge-impairments-in-children-with-adhd/2021-04-07T10:18:17-04:00https://www.caddra.ca/emotion-recognition-and-mind-wandering-in-adults-with-attention-deficit-hyperactivity-disorder-or-autism-spectrum-disorder/2021-04-14T09:37:18-04:00https://www.caddra.ca/a-novel-digital-intervention-for-actively-reducing-severity-of-paediatric-adhd-stars-adhd-a-randomized-controlled-trial/2021-04-21T10:18:16-04:00https://www.caddra.ca/caddra-and-caddac-call-on-provinces-to-prioritize-individuals-with-adhd-in-covid-19-vaccination-rollout/2021-04-22T11:46:00-04:00https://www.caddra.ca/adhd-and-risk-for-subsequent-adverse-childhood-experiences-understanding-the-cycle-of-adversity/2021-04-28T09:51:15-04:00https://www.caddra.ca/the-neurodevelopmental-nature-of-attention-deficit-hyperactivity-disorder-in-adults/2021-05-05T10:20:12-04:00https://www.caddra.ca/prospective-impact-of-covid-19-on-mental-health-functioning-in-adolescents-with-and-without-adhd-protective-role-of-emotion-regulation-abilities/2021-05-12T10:22:12-04:00https://www.caddra.ca/digital-health-interventions-dhi-for-the-treatment-of-attention-deficit-hyperactivity-disorder-adhd-in-children/2021-05-19T09:16:53-04:00https://www.caddra.ca/efficacy-of-cognitive-behavioural-therapy-in-medicated-adults-with-attention-deficit-hyperactivity-disorder-in-multiple-dimensions-a-randomised-controlled-trial/2021-05-26T09:10:53-04:00https://www.caddra.ca/which-factors-determine-clinicians-policy-and-attitudes-towards-medication-and-parent-training-for-children-with-attention-deficit-hyperactivity-disorder/2021-06-02T09:25:01-04:00https://www.caddra.ca/screening-for-adult-adhd-using-brief-rating-tools-what-can-we-conclude-from-a-positive-screen-some-caveats/2021-06-09T09:15:03-04:00https://www.caddra.ca/intervention-response-among-preschoolers-with-adhd-the-role-of-emotion-understanding/2021-06-16T10:37:25-04:00https://www.caddra.ca/comparable-emotional-dynamics-in-women-with-adhd-and-borderline-personality-disorder/2021-06-23T09:29:05-04:00https://www.caddra.ca/similarity-of-subjective-symptoms-between-autism-spectrum-disorder-and-attention-deficit-hyperactivity-disorder-in-adults-preliminary-findings/2021-06-30T09:44:53-04:00https://www.caddra.ca/evaluation-of-a-structured-skills-training-group-for-adolescents-with-attention-deficit-hyperactivity-disorder-a-randomized-controlled-trial/2021-07-07T09:29:50-04:00https://www.caddra.ca/adhd-with-developmental-coordination-disorder-24-year-follow-up-of-a-population-based-sample/2021-07-14T09:29:00-04:00https://www.caddra.ca/sleep-related-traits-and-adhd-comorbidity-shared-genetic-risk-factors-molecular-mechanisms-and-causal-effects/2021-07-21T09:19:28-04:00https://www.caddra.ca/asd-symptoms-in-adults-with-adhd-a-preliminary-study-using-the-ados-2/2021-07-28T09:33:21-04:00https://www.caddra.ca/predictors-of-treatment-engagement-and-outcome-among-adolescents-with-adhd-an-integrative-data-analysis/2021-08-04T09:15:22-04:00https://www.caddra.ca/half-of-the-children-with-overweight-or-obesity-and-adhd-reach-normal-weight-with-stimulants/2021-08-11T09:19:25-04:00https://www.caddra.ca/a-quality-improvement-initiative-to-improve-adhd-follow-up-rates-using-school-based-telemedicine/2021-08-18T09:10:59-04:00https://www.caddra.ca/comparing-the-initial-impact-of-covid-19-on-burden-and-psychological-distress-among-family-caregivers-of-children-with-and-without-developmental-disabilities/2021-08-25T09:38:43-04:00https://www.caddra.ca/placebo-and-nocebo-responses-in-randomized-controlled-trials-of-medications-for-adhd-a-systematic-review-and-meta-analysis/2021-09-01T09:37:01-04:00https://www.caddra.ca/intentional-discontinuation-of-psychostimulants-used-to-treat-adhd-in-youth-a-review-and-analysis/2021-09-08T10:10:06-04:00https://www.caddra.ca/caddra-and-caddac-call-for-all-federal-parties-to-address-inequities-to-access-to-mental-health-care-in-canada/2021-09-13T08:43:46-04:00https://www.caddra.ca/assessing-undertreatment-and-overtreatment-misuse-of-adhd-medications-in-children-and-adolescents-across-continents-a-systematic-review-and-meta-analysis/2021-09-15T09:35:19-04:00https://www.caddra.ca/a-placebo-controlled-trial-of-lisdexamfetamine-in-the-treatment-of-comorbid-sluggish-cognitive-tempo-and-adult-adhd/2021-09-21T13:37:49-04:00https://www.caddra.ca/the-association-between-symptom-severity-and-theory-of-mind-impairment-in-children-with-attention-deficit-hyperactivity-disorder/2021-09-29T09:17:45-04:00https://www.caddra.ca/contributions-of-friends-problem-behaviors-to-friendship-quality-in-a-sample-of-children-with-adhd/2021-10-08T10:44:50-04:00https://www.caddra.ca/improving-care-management-in-attention-deficit-hyperactivity-disorder-an-rct/2021-10-13T09:10:44-04:00https://www.caddra.ca/an-individual-participant-data-meta-analysis-behavioral-treatments-for-children-and-adolescents-with-attention-deficit-hyperactivity-disorder/2021-10-20T09:21:55-04:00https://www.caddra.ca/alpha2-adrenergic-agonists-or-stimulants-for-preschool-age-children-with-attention-deficit-hyperactivity-disorder/2021-10-27T09:57:31-04:00https://www.caddra.ca/annual-research-review-attention-deficit-hyperactivity-disorder-in-girls-and-women-underrepresentation-longitudinal-processes-and-key-directions/2021-11-03T11:54:05-04:00https://www.caddra.ca/time-perception-is-a-focal-symptom-of-attention-deficit-hyperactivity-disorder-in-adults/2021-11-10T09:13:43-05:00https://www.caddra.ca/variable-patterns-of-remission-from-adhd-in-the-multimodal-treatment-study-of-adhd/2021-11-17T09:04:23-05:00https://www.caddra.ca/diagnostic-and-medication-treatment-disparities-in-african-american-children-with-adhd-a-literature-review/2021-11-24T09:03:47-05:00https://www.caddra.ca/childhood-adhd-symptoms-parent-emotion-socialization-and-adolescent-peer-problems-indirect-effects-through-emotion-dysregulation/2021-12-01T10:37:30-05:00https://www.caddra.ca/sleep-quality-in-children-and-adolescents-with-attention-deficit-and-hyperactivity-disorder/2021-12-08T09:19:31-05:00https://www.caddra.ca/foquest-has-now-been-included-on-the-manitoba-formulary-as-of-november-2021/2022-01-11T11:28:50-05:00https://www.caddra.ca/concerta-has-now-been-updated-to-full-benefit-status-in-nova-scotia-new-brunswick-and-newfoundland-labrador/2022-01-11T11:34:39-05:00https://www.caddra.ca/a-program-to-improve-the-assessment-of-a-child-for-attention-deficit-hyperactivity-disorder/2022-01-12T09:13:16-05:00https://www.caddra.ca/driving-performance-and-cannabis-users-perception-of-safety-a-randomized-clinical-trial/2022-02-16T09:20:44-05:00https://www.caddra.ca/foquest-has-now-been-included-on-the-saskatchewan-formulary-as-of-march-2022/2022-03-03T09:26:54-05:00https://www.caddra.ca/action-plan-creating-equitable-access-to-adhd-care-in-canada/2022-03-16T09:36:26-04:00https://www.caddra.ca/pei-funds-the-first-provincial-adult-adhd-program-in-the-country/2022-04-14T10:26:39-04:00https://www.caddra.ca/the-impact-of-pharmacotherapy-of-childhood-onset-psychiatric-disorders-on-the-development-of-substance-use-disorders-2/2022-06-08T09:48:19-04:00https://www.caddra.ca/treatment-update-strattera-atomoxetine-capsules-to-be-discontinued-as-of-march-2023/2023-03-13T15:23:31-04:00https://www.caddra.ca/treatment-update-strattera-atomoxetine-capsules-to-be-discontinued-as-of-march-2023-2/2023-03-13T15:20:23-04:00https://www.caddra.ca/help-support-bill-c-329-the-national-framework-on-attention-deficit-hyperactivity-disorder-act/2023-04-11T10:21:14-04:00https://www.caddra.ca/newfoundland-and-labrador-expand-scope-of-practice-for-pharmacists-improves-access-to-adhd-medications-and-health-care/2023-04-11T10:27:11-04:00https://www.caddra.ca/foquest-has-now-been-included-on-the-quebec-formulary-as-of-april-2023/2023-04-13T10:10:53-04:00https://www.caddra.ca/foquest-has-now-been-included-on-the-ontario-drug-benefit-odb-formulary-as-of-april-28-2023/2023-04-28T08:44:46-04:00https://www.caddra.ca/advocacy-update-may-2023-meetings-with-provincial-ministers/2025-06-10T11:12:27-04:00https://www.caddra.ca/advocacy-update-june-2023-meetings-with-provincial-ministers/2025-06-10T11:10:34-04:00https://www.caddra.ca/double-blind-sham-controlled-randomized-trial-testing-the-efficacy-of-fmri-neurofeedback-on-clinical-and-cognitive-measures-in-children-with-adhd/2023-07-05T15:46:46-04:00https://www.caddra.ca/9298-2/2023-08-09T09:32:39-04:00https://www.caddra.ca/advocacy-update-meetings-with-provincial-ministers-july-august-2023/2025-06-10T10:30:40-04:00https://www.caddra.ca/foquest-has-now-been-included-on-the-newfoundland-and-labrador-prescription-drug-program-nlpdp-as-of-aug-30-2023/2023-09-08T10:06:45-04:00https://www.caddra.ca/new-nova-scotia-pilot-program-to-address-adhd-and-asd-wait-lists/2023-09-13T11:45:24-04:00https://www.caddra.ca/new-adhd-meds-on-alberta-drug-benefit-list/2023-11-01T19:33:03-04:00https://www.caddra.ca/vyvanse-added-to-innovicares-program/2023-11-01T19:36:23-04:00https://www.caddra.ca/foquest-now-on-the-alberta-drug-benefit-list/2023-11-13T04:44:08-05:00https://www.caddra.ca/foquest-is-now-covered-on-the-nova-scotia-formulary/2023-12-07T13:47:37-05:00https://www.caddra.ca/foquest-is-now-listed-on-the-pei-formulary/2023-12-19T16:26:14-05:00https://www.caddra.ca/commentary-on-adhd-medications-and-long-term-risk-of-cardiovascular-diseases/2025-12-04T14:15:04-05:00https://www.caddra.ca/foquest-is-now-covered-on-the-new-brunswick-formulary/2024-02-22T12:12:23-05:00https://www.caddra.ca/caddra-2025-summary/2026-01-11T03:06:23-05:00https://www.caddra.ca/welcoming-dr-emma-a-climie-to-the-caddra-board/2025-11-25T14:06:29-05:00https://www.caddra.ca/welcoming-dr-marie-helene-geoffroy-to-the-caddra-board/2025-11-25T15:51:36-05:00https://www.caddra.ca/changes-to-caddra-board-of-directors/2025-11-25T15:59:13-05:00https://www.caddra.ca/januarys-fireside-chat-recording-now-available/2026-02-25T10:54:55-05:00https://www.caddra.ca/adhd-her-a-research-study-on-girls-and-womens-experiences-with-adhd/2026-02-25T13:54:11-05:00https://www.caddra.ca/registration-is-open-for-adhd-intensive-2026/2026-02-25T13:54:02-05:00https://www.caddra.ca/cannabis-and-adhd/2026-05-22T09:40:01-04:00https://www.caddra.ca/caddra-hybrid-intensive-2026/2026-07-14T15:41:59-04:00https://www.caddra.ca/courses-are-now-free-with-membership/2026-07-14T15:18:19-04:00https://www.caddra.ca/caddra-at-cacap/2026-07-14T15:53:38-04:00https://www.caddra.ca/updated-medication-chart/2026-07-14T16:35:04-04:00